Market map

Cardiovascular

The cardiovascular technology sector is rapidly transitioning toward AI-driven diagnostics and decentralized patient care, fueled by substantial investments in remote cardiac monitoring, advanced echocardiography analysis, and cloud-based electrocardiogram tools that enhance clinical workflow efficiency.

30 companies, 17 sub-segments, from our own research

The desk's read

  • Remote cardiac monitoring and artificial intelligence powered electrocardiogram analysis represent crowded sub-segments, with numerous regional players offering diverse cloud solutions.

  • Specialized niches like epigenetic cardiac diagnostics and microvascular diagnostics remain thin, with few competitors addressing these highly specific clinical areas.

  • Financial capital is heavily concentrated in North America, with market leaders in personal ECG, digital stethoscopes, and imaging AI securing the largest funding rounds.

  • Buyers should monitor early-stage startups developing handheld echocardiography AI and non-invasive heart failure management tools that simplify point-of-care diagnostics.

Personal ECG monitoring

2

Ambulatory cardiac monitoring

2

Cardiac device management

2

Electrocardiogram analysis AI

2

Smartphone cardiac detection

2

Digital stethoscopes

1

Echocardiography analysis AI

1

Microvascular diagnostics

1

Arrhythmia mapping

1

Epigenetic cardiac diagnostics

1

Cardiac device monitoring

1

Digital auscultation

1

Heart failure management

1

Our own research, our own segmentation. Browse every Cardiovascular company or open the full database.